Current Vascular Pharmacology
Current Vascular Pharmacology publishes clinical and research-based reviews/mini-reviews, original research articles, letters, debates, drug clinical trial studies, and guest-edited issues to update all those concerned with the treatment of vascular disease, bridging the gap between clinical practice and ongoing research.
Vascular disease is the most common cause of death in Western countries, and its incidence is on the rise in developing countries. It follows that considerable research is directed at establishing effective treatment for acute vascular events. Long-term treatment has also received considerable attention (e.g., for symptomatic relief). Furthermore, effective prevention, whether primary or secondary, is backed by the findings of several landmark trials. Vascular disease is a complex field with primary care physicians and nurse practitioners, as well as several specialties involved. The latter include cardiology, vascular and cardiothoracic surgery, general medicine, radiology, clinical pharmacology, and neurology (stroke units).
Current Vascular Pharmacology is an international, peer-reviewed journal on all aspects of vascular pharmacology, published bi-monthly (print & online) by Bentham Science Publishers.
| Language | English |
|---|---|
| Active |